DaSalva Leaves BMS to Join GCI Healthcare
Charting the future of public relations
Holmes Report
CEO

DaSalva Leaves BMS to Join GCI Healthcare

Veteran pharmaceutical industry communications executive AnnaMaria DeSalva has joined GCI Group as executive vice president at GCI Healthcare North America.

Paul Holmes

NEW YORK, May 7—Veteran pharmaceutical industry communications executive AnnaMaria DeSalva has joined GCI Group as executive vice president at GCI Healthcare North America. DaSalva most recently spent five years in international public affairs and strategic philanthropy with Bristol-Myers Squibb Company.
 
DeSalva will also join GCI’s global healthcare board, which was formed to discuss marketplace and client issues on a regular basis.  The board includes Alan Archer, GCI U.K., who was formerly with Glaxo and the Financial Times; Bob Pearson, GCI The Americas, who was with Novartis and Rhone-Poulenc Rorer; Steve Dickinson, GCI Atlanta, who worked for the American Cancer Society and Searle; Dr. Horst Muther, GCI Healthcare/Hamburg, who was with Burson Marstellar and Glaxo; and Ilyssa Levins, GCI New York. 
 
“Anna Maria’s hire is symbolic of how we are building our healthcare practice worldwide,” said Bob Pearson, president of GCI The Americas.  “She has worked on a domestic and global scale, she has worked as a consultant and as a client, and she has worked to support products and corporate initiatives.  She is the type of person who can provide great counsel at any level in virtually any type of a situation for our clients.”
 
DeSalva will oversee the healthcare practice in North America, which includes pharmaceuticals, clinical trial recruitment, biotechnology, consumer health, medical devices and provider care.
 
DeSalva joined BMS’s International Public Affairs Department in 1996 and was responsible for worldwide and European communications strategies to drive access to and usage of the company’s oncology product portfolio. Prior to her tenure at BMS, DeSalva was a vice president in the healthcare and pharmaceutical practice of Ketchum. 
View Style:

Load 3 More
comments powered by Disqus